INTRODUCTION

20
The 1000 Genomes Project (1KGP) was designed to provide a comprehensive description of human genetic variation 21 through sequencing multiple individuals [1] [2] [3] . Specifically, the 1KGP provides a list of variants and haplotypes that can be 22 used for evolutionary, functional and biomedical studies of human genetics. Over the three phases of the 1KGP, a total of 23 2504 individuals across 26 populations were sequenced. These populations were classified into 5 major continental 24 2 groups: Africa (AFR), America (AMR), Europe (EUR), East Asia (EAS), and South Asia (SAS). The 1KGP data was generated 25 using a combination of multiple sequencing approaches, including low coverage whole genome sequencing with mean 26 depth of 7.4X, deep exome sequencing with a mean depth of 65.7X, and dense microarray genotyping. In addition, a subset 27 of individuals (427) including mother-father-child trios and parent-child duos were deep sequenced using the Complete
28
Genomics platform at a high coverage mean depth of 47X. The project involved characterization of biallelic and 29 multiallelic SNPs, indels, and structural variants.
30
Given the low depth of (sequencing) coverage for most 1KGP samples, it is unclear how accurate the imputed haplotypes 31 are, especially for rare variants. We quantify this accuracy directly by comparing imputed genotypes and haplotypes 32 based on low-coverage whole-genome sequence data from the 1KGP with highly accurate, experimentally determined 33 haplotypes from 28 of the same samples. Additional motivation for our study is given below.
34
Phasing It is important to understand phase information in analyzing human genomic data. Phasing involves resolving
35
haplotypes for sites across individual whole genome sequences. The term 'diplomics' 4 has been coined to describe 
41
Phasing methods can be categorized into methods which use information from multiple individuals and those which rely 42 on information from a single individual 5 . The former are primarily computational methods, while the latter are mostly 43 experimental approaches. Some computational approaches use information from existing population genomic databases 44 and can be used for phasing multiple individuals. These, however, may be unable to correctly phase rare and private 45 variants, which are not represented in the reference database used. On the other hand, some methods use information 46 from parents or closely related individuals. These have the advantage of being able to use Identical-By-Descent (IBD) 47 information, and allow long range phasing, but require sequencing of more individuals, which adds to the cost. A few 48 methods which use these approaches are: PHASE 6 , fastPHASE 7 , BEAGLE 8-9 , SHAPEIT 10-11 , EAGLE 12-13 and IMPUTE v2 14 .
49
Experimental phasing methods, on the other hand, often involve separation of entire chromosomes followed by 50 sequencing of short segments, which can then be computationally reconstructed to generate entire haplotypes. These 51 methods do not need information from individuals other than the one being sequenced. These methods involve 52 3 genotyping being performed separately from phasing. These methods fall into two broad categories, namely dense and 53 sparse methods 14 . Dense methods resolve haplotypes in small blocks in great detail, where all variants in a specific region 54 are phased. However, they do not inform the phase relationship between the haplotype blocks. These involve diluting 55 high molecular weight DNA fragments such that fragments from at most one haplotype are present in each unit. Sparse 56 methods can resolve phase relationships across large distances, but may not inform on the phase of each variant in a 57 chromosome. In these methods, a low number of whole chromosomes is compartmentalized such that only one of each 58 pair of haplotypes is present in each compartment. These compartmentalizations are followed by sequencing to generate 59 the haplotypes.
60
In this work, we use phased haplotypes generated using the 10X Genomics method which uses linked-read sequencing 15 .
61
1 nanogram of high molecular weight genomic DNA is distributed across 100,000 droplets. This DNA is barcoded and 62 amplified using polymerase. This tagged DNA is released from the droplets and undergoes library preparation. These 
65
Imputation Imputation involves the prediction of genotypes not directly assayed in a sample of individuals.
66
Experimentally sequencing genomes to a high coverage is an expensive process. Low coverage sequencing or arrays can 67 be used as low-cost methods for sequencing. However, these methods may lead to uncertainty in estimated genotypes
68
(low coverage sequencing) or missing genotype values for untyped sites (arrays). Imputation can be used to obtain 69 genotype data for missing positions using reference data and known data at a subset of positions in individuals which 70 need to be imputed. Imputation is used to boost the power of GWAS studies 16 , fine mapping a particular region of a 71 chromosome 17 , or performing meta-analysis 18 , which involves combining reference data from multiple reference panels.
72
Imputation uses a reference panel of known haplotypes with alleles known at a high density of haplotyped positions. A 73 study/inference panel genotyped at a sparse set of positions is used for sequences which need to be imputed. Performing 74 imputation involves two basic steps:
75
• Phasing genotypes at genotyped positions in the study/inference panel 76
• Haplotypes from the inference panel which match those in the reference panel at the positions in the study panel 77
are assumed to match in all other positions
78
Various imputation algorithms perform these steps sequentially and iteratively or simultaneously.
4
Factors affecting the quality of the phasing and imputation are (1) 
123
Preprocessing 1000 Genomes Data
124
The 1000 Genomes data was separated into individual and chromosome specific VCFs using vcftools 25 . Further, the 125 variants were filtered for biallelic SNPs, phased, filtered for PASS, and indels were removed. The experimentally phased 126 data also had a very small fraction of unphased SNPs, which were removed by filtering with vcftools. The analysis was 127 performed only for autosomes. 
145
Imputation Analysis
146
The entire imputation analysis is performed for each chromosome for each individual.
147
Generate Recombination Map IMPUTE v2 13 makes available recombination maps for each chromosome using the 1000
148
Genomes data for the GRCh37 assembly. A recombination map was obtained for each chromosome for GRCh38 by lifting 149 over the GRCh37 maps using the liftover software. ~8k positions (0.2%) were removed from the lifted over 150 recombination map because liftover resulted in them being in the incorrect order.
151
Generate Reference Panel A reference haplotype panel was generated for all individuals from the 1000 Genomes data by 152 subsetting it to the specific population of interest. 1000 Genomes data for the individuals which were experimentally 153 sequenced was not included in the reference panel. vcftools was used to filter out the individuals of interest from the 1000 7 Genomes data. bcftools was used to convert the VCF data to haps-sample-legend format. An alternate approach was also 155 used, where the entire 1000 Genomes data was used to generate a reference haplotype panel.
156
Generate Study Panel A study panel was generated for the experimentally sequenced individuals selected. The study 157 panel is assumed to be genotyped at positions corresponding to the Illumina InfiniumOmni2.5-8 array. Array positions 158 were lifted over from GRCh37 to GRCh38 using liftover. 1000 Genomes haplotypes (since 1000 Genomes data is 159 prephased, the study panel is also in the form of haplotypes rather than genotypes) for those positions for those 160 individuals were selected to create the study panel using vcftools. Filtered VCF files were converted to the haps-sample 161 format using bcftools.
162
Run Imputation Missing positions are imputed using IMPUTE v2. Imputation was performed in 5Mb windows. The 163 genotype output by imputation was converted to VCF format using bcftools. VCFs produced over all windows were 164 combined using vcf-concat. IMPUTE v2 generally phases the typed genotyped sites in study panel. This is followed by 165 imputation which is performed by assuming that haplotypes in the study panel that match the haplotypes in the reference 166 panel at the typed sites also match in the untyped sites. IMPUTE v2 then performs an iterative process performing 167 multiple Monte-Carlo steps alternating phasing and imputation. For this analysis, however, as haplotypes from the 1000
168
Genomes project were directly used to generate the study panel, the phasing step was not performed. 
176
Imputation Error Imputation error was computed as fraction of genotypes being incorrectly identified. Imputation error 177 was computed for both, the SNPs in the experimental data and all the SNPs in 1000 Genomes data. Error is computed as a 178 function of minor allele frequency. The continent-specific minor allele frequencies were used for analyzing the imputation 
200
RESULTS
201
The 1000 Genomes project chromosome-specific VCFs for the GRCh38 assembly contain between 6.4M (chr1) to 1.1M 
211
Genomes SNPs
212
The SNPs from the experimentally phased VCFs (Fig. 1a) , averaged over continent groups show that the vast majority of 
219
These discrepancies between the numbers in the 1000 Genomes data and in the experimentally phased data, as well as 
223
This results in a much larger number of overall SNPs being present in the 1000 Genomes data as compared to the 224 experimental and also the majority of the 1000 Genomes SNPs having extremely low MAF, as those would occur only in 
236
There is higher error at the population invariant sites (MAF=0.0%) in the African and American populations than the
237
European, East Asian and South Asian populations. This correlates with a lower total number of population invariant
238
SNPs in those continents (Fig. 1a) . For non-invariant SNPs, we observe, as expected, a decreasing error rate with 239 increasing minor allele frequency, to a <1.5% error genotyping error rate for the SNPs with minor allele frequencies > 1%.
240
Comparing false positive (sites non-homozygous reference in 1000 Genomes data and homozygous reference in the 241 experimental data) vs false negative (sites homozygous reference in 1000 genomes data and non-homozygous reference 242 in the experimental data) error rates for all 1000 Genomes sites (Fig. 1b) , we see that the genotyping for the European
243
and American individuals is very accurate, with both low false positive and false negative rates. The East Asian and South
244
Asian populations both have mostly low false positive rates, but show a wide range (factor of 2) of false negative rates,
245
while showing only a ~15% variation in the false positive rates for most individuals. In contrast, the African individuals 
253
Phasing errors are all analyzed for overall 1000 Genomes minor allele frequencies, not continent specific MAFs.
254
Comparing the switch error across individual chromosomes (Fig. 3) , we observe that the switch error ranges between 25
255
− 30% for the rare MAF (< 0.1%) SNPs, falling to < 5% for SNPs with MAFs 1 − 5%. The majority of SNPs, which fall in the
256
MAF > 5% category, have an error < 2.5%. However, a comparatively higher switch error at larger MAF values (> 5%) is 257 observed for chromosome 21. This plot (Fig. 3) shows only a subset of chromosomes a single individual (GM18552), but 
12
Analyzing the switch error as a function of minor allele frequency averaged over all chromosomes of all individuals of a 269 population (Fig. 4b) , we observe low switch error, < 5%, for low minor allele frequencies (MAF) (1 − 5% 
273
As observed in Figure 4c , the differences in the error rates between individuals decrease with increasing minor allele 
283
We also analyzed phasing error as a function of the distances between SNPs (Fig. 5) . The phasing error increases as a (Fig. 4c) .
288
Comparing the switch error as a function of MAF vs. the switch error as a function of inter-SNP distance, we see that the (Fig. 1a) , as well as an overall higher number of SNPs
293
in those individuals, leading to a higher SNP density for these individuals. In addition, there is less linkage disequilibrium
294
(LD) in the individuals from the African populations, which would make it harder to phase them accurately [29] [30] . Hence,
295
pairs of SNPs are more likely to be out of phase with each other, leading to higher switch error as a function of inter-SNP 296 distance. 307 Figure 6a shows the total imputation error in the experimental SNPs while Figure 6b shows the total imputation error in 
327
higher MAF values are fairly accurate, with errors < 2% for common SNPs (MAF > 5%). This can also be seen looking at all 328 the individuals separately (Fig. 7b) . The South Asian (Gujarati in Houston, Texas) individual NA20900 still shows the 329 lowest error rate as a function of MAF for imputation, just as it does for the switch error (Fig. 4c) . 
335
Imputation error in all 1KG SNPs Computing the error using all the 1KG SNPs, we see a different trend for the errors as 336 a function of minor allele frequency (Figs. 8a, 8b) . The invariant sites have very low errors ~10 -4 . For the variant sites, the 337 errors increase as a function of minor allele frequency, as opposed to decreasing as they do in the experimental only SNPs.
338
The reason this happens is that contrasting the number of experimental SNPs (Fig. 1a) with the numbers of all 1KG
339 SNPs (Fig. 1b) , while the number of low MAF SNPs is 1-2 orders of magnitude less than the number of SNPs with MAF >
340
5% in the experimental data, the number of very low MAF SNPs is 2-10 times greater than the number of SNPs with MAF
341
> 5% in the whole 1000 Genomes data. The vast majority of the very low MAF SNPs in the whole 1000 Genomes data are 
362
The observed result for experimental only SNPs (Fig. 8a ) when comparing reference panels for the European individuals 363 is very similar when looking at all 1000 Genomes SNPs (Fig. 8b) . The imputation accuracy when using the entire 1000
364
Genomes data as a reference panel gives a slightly better accuracy than using just a European specific reference panel.
365
The error while using an incorrect reference panel, however, is up to a factor of 2 greater than the error when using the 366 appropriate reference, or when using the whole 1000 Genomes reference panel. The trend of error as a function of MAF is,
367
again, the opposite of what was observed when looking at only the experimental SNPs.
368
DISCUSSION
369
The 1000 Genomes Project data have been widely used as a reference for estimating continent-specific allele frequencies,
370
and as a reference panel for phasing and imputation studies. Since the project's design involved low-coverage (~7X) with European ancestry, additional large-scale genome sequencing of diverse human populations will be necessary to
394
obtain comparable benefits of imputation in genetic association studies of non-European groups.
396
Finally, we note that the absolute error rate varied by an order of magnitude, depending on the specific definitions of 397 error that were used. This highlights the importance of definitional clarity in studies that evaluate the accuracy of 398 genomic resources.
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